ISICEM 2018 Congress Video Highlights

View the collection of symposium videos and faculty interviews from ISICEM 2018 below. 

Symposium Videos: 

Video 1 - David Nicolau:

  • Pharmacology of a novel β-lactam/β-lactamase inhibitor: ceftazidime–avibactam

Video 2 - Alex Soriano:

  • Use of ceftazidime–avibactam in difficult-to-treat infections: clinical experience and real-world evidence

Video 3 - Paurus Irani:

  • Multidrug-resistant HAP/VAP treatment: an alternative option

Faculty Interviews: 

Video 1-  Phillipe Montravers: 

  • Patients suitable for treatment with ceftazidime–avibactam
  • The impact of ceftazidime–avibactam availability in France

Video 2- David Nicolau :                

  • Challenges in the management of multidrug-resistant Gram-negative infections
  • The role of ceftazidime–avibactam in maximising clinical and microbiological outcomes
  • Maximising efficacy through early targeted therapy
  • Identifying the right patients for empiric treatment with ceftazidime–avibactam
  • The rationale behind the dose of ceftazidime–avibactam

Video 3-  Alex Soriano :                  

  • ISICEM presentation: summary
  • Ceftazidime–avibactam in patients with limited treatment options
  • Patient risk factors for empiric therapy
  • The impact of ceftazidime–avibactam availability in Spain


Symposium Video 1 - David Nicolau:

Symposium Video 2 -  Alex Soriano

Symposium Video 3 - Paurus Irani

Faculty Interview Video 1 -  Phillipe Montravers

Faculty Interview Video 2 - David Nicolau

Faculty Interview Video 3  - Alex Soriano


Date of Preparation: January 2018